Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. (Q39215504)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. |
scientific article |
Statements
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia (English)
Katherine S Panageas
Nicole Lamanna
Matt Kalaycio
Joseph G Jurcic
Mark Heaney
Renier Brentjens
Denise Horgan
Alison Gencarelli
David A Scheinberg